GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jingxin Pharmaceutical Co Ltd (SZSE:002020) » Definitions » Tax Expense

Zhejiang Jingxin Pharmaceutical Co (SZSE:002020) Tax Expense : ¥125 Mil (TTM As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Jingxin Pharmaceutical Co Tax Expense?

Zhejiang Jingxin Pharmaceutical Co's tax expense for the months ended in Dec. 2024 was ¥29 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2024 was ¥125 Mil.


Zhejiang Jingxin Pharmaceutical Co Tax Expense Historical Data

The historical data trend for Zhejiang Jingxin Pharmaceutical Co's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jingxin Pharmaceutical Co Tax Expense Chart

Zhejiang Jingxin Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 105.65 81.57 82.49 84.62 124.85

Zhejiang Jingxin Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.48 28.91 45.35 21.65 28.95

Zhejiang Jingxin Pharmaceutical Co Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥125 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Jingxin Pharmaceutical Co  (SZSE:002020) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Zhejiang Jingxin Pharmaceutical Co Tax Expense Related Terms

Thank you for viewing the detailed overview of Zhejiang Jingxin Pharmaceutical Co's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Jingxin Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.800 Xinchang East Road, Yulin subdistrict, Zhejiang Province, Xinchang, CHN, 312500
Zhejiang Jingxin Pharmaceutical Co Ltd is an integrated pharmaceuticals enterprise that focuses on manufacturing, R&D, and marketing. It offers finished dosage forms which include tablets, capsules, and injections in the areas of antilipemic, antidiabetic, cholesterolemia, luoroquinolones, cephalosporin, gastrointestinal promotion, anti-inflammatory analgesic, and antibiotics; APIs, and Chinese herbal drugs. The products are sold to overseas markets such as South-east of Asia, South Asia, Latin America and Europe.
Executives
Wang Neng Neng Director
Chen Shao Bi Executives
Wang Guang Qiang Supervisors
Lv Gang Director
Zhou Lin Executives
Yu Yi Ping Supervisors
Chen Mei Li Directors, executives
Zhang Li Wa Directors, executives
Wu Zheng Jie Director

Zhejiang Jingxin Pharmaceutical Co Headlines

No Headlines